about
Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitisThe second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificitySerum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer.Digitalis--a bicentennial progress report.Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A.Simultaneous synthesis of human-, mouse- and chimeric epidermal growth factor genes via 'hybrid gene synthesis' approachSynthesis and delivery of short, noncoding RNA by B lymphocytes.Immunogenicity of an engineered internal image antibody.Monoclonal antibodies: their importance to surgeons.Immunotoxicotherapy: present status and future trends.Antigenicity and immunogenicity of antigenized antibodies. Studies on B and T cells.Antibody-targeted drugs for the therapy of cancer.The major rheumatoid factor cross-reactive idiotype in rheumatic disease.Th2-dominated antitumor immunity induced by DNA immunization with the genes coding for a basal core peptide PDTRP and GM-CSF.Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2.In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen.Hyperosmotic pressure enhances immunoglobulin transcription rates and secretion rates of KR12H-2 transfectoma.A human monoclonal antibody recognizing a surface antigen on stomach cancer cells.Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial
P2860
Q24791647-206BBBEB-B0D5-4275-964C-D3AB67CD183FQ33581541-F78D3473-6E96-403B-BF90-40E15844EF34Q33586088-179DB330-31D9-4DEC-B39C-013FF66F8991Q33712484-EF9D4CB1-73C9-4EF0-8691-F01DF8F9FD40Q33867651-C7E29B22-5863-438C-A42E-B6A5E427145FQ34116897-5D36F615-763B-45DC-8153-396512ABBE99Q34194028-9A829AE5-37C4-4930-BCE6-90A328530EF5Q34586012-DA8C0F2C-F48D-4BAE-8122-BD4AA8A0979CQ35048894-4F35F406-C421-4CAC-8496-30C80E008BB6Q37395027-9CD89A06-F41A-417D-9C71-F62B90E9C1CAQ37521191-0B7C69D8-E521-4C53-B2DC-2CDA57034B91Q38215737-DC86867F-3064-4C3F-97ED-1B5288D9466AQ38682222-5924FAB7-8AD0-411D-819A-033D85B866AFQ40489535-0F4EC16E-DAD9-4A43-AC4D-A3682D7C2AEDQ40563987-DB330010-281F-4E4F-80BB-98F8D6F1D12FQ41021996-BB73A91A-1961-4736-BAC7-AEF7746A2326Q42487727-557F06F5-9A51-4B75-B19B-68385A8E0B0DQ42801724-23B7087B-3674-4F24-B8AC-D1DAC8720FD6Q45762700-68EC1D0F-4285-4984-BF82-21ED5A64100FQ52080309-C6FF8F44-9677-4B0F-AA15-A768ED059618Q55317230-9884AC52-CDCF-469F-9D11-76A0AB28B9FCQ56574975-1E0BEB89-6BFD-406C-BD34-FA06E9213A74
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Transfectomas provide novel chimeric antibodies.
@en
Transfectomas provide novel chimeric antibodies.
@nl
type
label
Transfectomas provide novel chimeric antibodies.
@en
Transfectomas provide novel chimeric antibodies.
@nl
prefLabel
Transfectomas provide novel chimeric antibodies.
@en
Transfectomas provide novel chimeric antibodies.
@nl
P356
P1433
P1476
Transfectomas provide novel chimeric antibodies.
@en
P2093
Morrison SL
P304
P356
10.1126/SCIENCE.3929380
P407
P577
1985-09-01T00:00:00Z